Floatz logo

2-BUTENEDIOIC ACID, (2E)-, DIMETHYL ESTER

Adult Giant Cell Glioblastoma

Virginia Commonwealth UniversitySmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Adult Giant Cell Glioblastoma cohort.

Asset / SponsorPhaseRating
Irinotecan
Case Comprehensive Cancer Center
Phase 2BBB
Cediranib
Lawrence Recht
Phase 2BBB
Temsirolimus
National Cancer Institute (NCI)
Phase 2BBB
2 (1H))-QUINOLINONE,6-(AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-4-(3-CHLOROPHENYL)-1-METHYL-,(+)-
National Cancer Institute (NCI)
Phase 2BB
Rindopepimut
Celldex Therapeutics
Phase 3BB

View all 50 →

Same molecule, other indications

2-BUTENEDIOIC ACID, (2E)-, DIMETHYL ESTER is also rated in:

relapsing-remitting multiple sclerosisDormant
BBB
Indicative ·
76 / 100
View asset →
multiple sclerosisDormant
BB
Indicative ·
67 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →